Meet us at Phacilitate Advanced Therapies Week • January 18–21, 2027!

Tomorrow's Cell Therapies, Today®

Standardized iPSC starting materials for cell therapies and human cell models.

Low-passage, polyclonal cell lines. Prequalified high-density RTD® vials. Optimized, ready-to-use culture systems.

LOW-PASSAGE iPSCs • SAFETY-ENABLED ENGINEERING • PREQUALIFIED RTD®
Microscopy-based cell imagery from a Pluristyx presentation
✳From the cell line to
the finished application.

One cellular foundation.
Multiple paths to discovery and therapy.

Explore standardized starting materials, optimized workflows, and custom capabilities designed to work together.
See what we offer ↗
01 / OUR PRODUCTS

Explore the products that fit your workflow.

Prequalified iPSC vials and complete, optimized cell culture systems, with dedicated routes for therapy development and human cell models.

Browse Product Catalog ↗
iPSC colony in culture01
INTEGRATED CULTURE SYSTEM

PluriKit™

Cells, medium, and matrix. Designed to work together.

RTD® cells supplied with matched medium and matrix to simplify culture and minimize adaptation-related variability.

Explore PluriKit ↗
Microscopy of cultured iPSC aggregates02
HIGH-DENSITY STARTING MATERIAL

RTD® iPSC Vials

Standardized. Prequalified. Ready to differentiate.

QC-tested, high-density cryopreserved cells that can eliminate approximately 10 days of conventional pre-differentiation expansion, depending on workflow.

Explore RTD iPSCs ↗
Fluorescent 3D iPSC aggregates from Pluristyx data03
2D / 3D CELL MODEL SYSTEMS

PluriForm™ Kits

Simplify the path from iPSCs to human cell models.

Integrated cell and reagent systems for reproducible iPSC culture, aggregate generation, and advanced research applications.

Explore PluriForm ↗
WHY RTD®

Thaw. Culture. Differentiate.

High-density prequalified vials simplify your starting workflow. PluriKit extends that consistency with matched medium and matrix.

Find your iPSC solution ↗
ConventionalThaw → Expand ~10 days → Differentiate
RTD®Thaw → Begin your workflow
Illustrative workflow comparison; timing varies by cell line and process.
✳
Find your cell line. Pluristyx offers unedited and engineered iPSC options for different development needs. Explore PluriBank →
PRODUCT SELECTION

Not sure which format fits your application?

Compare standalone RTD® vials, complete PluriKit™ culture systems, and PluriForm™ kits for 2D/3D models.

Use the Product Guide ↗
02 / THE PLURISTYX ADVANTAGE

Built differently. Delivered consistently.

Rapid polyclonal reprogramming, engineered safety and immune evasion, and standardized ready-to-use formats are designed to work together.

01 CREATE
◎

Stemloop®

Rapid, low-passage, polyclonal iPSCs.

Proprietary mRNA reprogramming rapidly generates low-passage, polyclonal iPSC populations, providing an advantageous starting material for downstream genetic engineering.

Explore reprogramming ↗
02 ENGINEER
◇

FailSafe® + iACT™

FailSafe® safety switch + iACT immune evasion.

FailSafe® provides a drug-inducible safety mechanism for unwanted proliferating cells. iACT provides immune-evasion engineering for allogeneic applications. Configurations vary by cell line.

03 DELIVER
▤

RTD® + PluriKit™

Prequalified, high-density, ready-to-use cells.

RTD® cells are manufactured using standardized processes and QC-tested against defined specifications. Their high-density format reduces or eliminates pre-differentiation expansion.

View product formats ↗
i

Low-passage starting cells reduce opportunities for culture-associated genetic changes. Standardized RTD® manufacturing and release testing help control variability. Performance remains line- and application-dependent.

03 / WHERE OUR PRODUCTS WORK

One foundation. Two major markets.

The same quality-focused iPSC platform supports very different commercial applications.

Fluorescence microscopy from a Pluristyx presentation
APPLICATION 01

Cell therapy
development

Clinical-path starting materials, engineered cell lines, safety technologies, and support for allogeneic programs.

Explore the pathway ↗
iPSC aggregates in suspension culture
APPLICATION 02

Human cell models
& NAMs

Standardized iPSCs and integrated kits for 2D/3D models, organoids, disease research, and screening.

Explore PluriForm ↗
04 / CUSTOM SERVICES

Your program.
Our expertise.

More than a product catalog, we're a technical partner for development and adoption.

Explore development services ↗
01

Custom reprogramming

Generate patient- or donor-specific iPSCs using Pluristyx expertise.

02

Genetic engineering

Custom edits, clone selection, and engineered line development.

03

Characterization & banking

Analytical characterization, qualified cell banks, and manufacturing support.

04

Application support

Help customers establish suitable workflows around our products.

Microscopy image showing iPSCs grown as suspension aggregates
Pluristyx RTD iPSC microscopy
05 / SCIENTIFIC VALIDATION

Performance you can examine.

Make decisions with data, not just claims. Our team characterizes cell identity, viability, pluripotency, genetic stability, and performance in downstream workflows.

Post-thaw viabilityGenetic stabilityCell identityDifferentiation
Explore the science ↗
06 / RESOURCES & SUPPORT

Answers beyond the vial.

Protocols, publications, technical guidance, and application data in one place.

CUSTOMER LIBRARY • CONCEPT
Coming in a later phase: customer registration, protected IFU downloads, activity tracking, and searchable technical documentation.
Cloudflare R2 + D1 + Workers

Quick answers

A sample of the planned technical FAQ area.

What is an RTD iPSC vial?+

Ready-to-Differentiate® is Pluristyx's high-density cryopreserved iPSC format designed to reduce or eliminate pre-differentiation expansion. The appropriate workflow depends on the specific line and application.

Why offer PluriKit instead of cells alone?+

Culture medium, matrix, and handling conditions affect cellular behavior. PluriKit packages compatible materials and instructions intended to support consistent growth and reduce adaptation-related variability.

Are all lines engineered with FailSafe and iACT?+

No. Pluristyx offers unedited and engineered configurations. Available cell lines, engineering features, and licensing terms should be confirmed with the team.

How can I evaluate a line before commercial licensing?+

Pluristyx commonly offers Limited Use License arrangements for evaluation, followed by separate commercial licensing discussions if the line fits the customer's program.

07 / WORK WITH PLURISTYX

From first evaluation to long-term supply.

A practical path for selecting and adopting Pluristyx products and technologies.

01

Evaluate

Test candidate lines and systems under an appropriate Limited Use License, often over a 6–18 month evaluation period.

02

Develop

Select an unedited, FailSafe, or iACT + FailSafe configuration. Use product and custom development support as needed.

03

Commercialize

Discuss commercial licensing and establish supply of cell lines, RTD vials, and kits for ongoing programs.

LET'S START WITH YOUR APPLICATION

What are you building?

Tell us about your cell line, culture system, or development requirements.

Talk to our team ↗